Contract Manufacturing of Drug Products

Intermediates

Others

Bayer is offering CDMO Services for Biotechnological Products! The Future is Now. Bayer is your reliable Partner for your Innovation. 
You are looking for a partner to develop and commercialize you biotechnological asset? 
Whether it is a Protein, a Cell Therapy or Gene Therapy Product...

API

API

Bayer is offering Contract Manufacturing of APIs. At Bayer we offer Contract Manufacturing Services for APIs from our API Manufacturing Sites in Germany, Spain and Mexico with a wide range of capabilities from Classical Chemical Synthesis to Biotransformation including handling and recovery of Solvent...

Progestogens

Estrogen

Estrogen

Estrogens

Progestogens

Progestogens

You will know Bayer as manufacturer of innovative high-quality API and Drug Products. 

But do you know that Bayer offers as well Contract Manufacturing?

Schedule a meeting with us now at CPhI in Frankfurt. We are happy to introduce you to our global manufacturing network with a footprint in Europe, Mexico, China and Japan.

We offer tailored solutions for your product:From Small Molecules to Large Molecules
From classical API synthesis to biocatalysis, 
From formulation of semisolids or tableting to aseptic manufacturing of prefilled syringes.
 

We look forward to hearing from you

Check out our CMO Brochure to learn more about the capabilities of our global API and DP manufacturing network and so many other excellent reasons to partner with Bayer.

This episode of the CPHI Podcast Series, hosted by Digital Editor Lucy Chard, goes through the results from the recent audits from the PSCI conducted on suppliers across the pharmaceutical industry, looking into ESG outcomes. 

The PSCI have launched their framework for suppliers in the pharmaceutical and health industry for increasing social and environmental responsibility, complete with guides and resources, all showcased in a helpful webinar. 

Provision of healthcare is an important aspect of people's lives, especially those in the LGBTQIA+ community. Pharmaceutical companies are working to improve this access to medicine and representation for the population. 

The March episode of the CPHI Podcast Series is dedicated to celebrating International Women's Day, followng the theme #EmbraceEquity in the context of women's health. 

The CDMO's fivefold capacity increase will provide early preclinical through to commercialisation support

The company expects to complete its building and modernising plans in Turku by 2025